Janney Montgomery Scott
EW icon

Janney Montgomery Scott’s Edwards Lifesciences EW Stock Holding History

Janney Montgomery Scott’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.05M Sell
50,558
-615
-1% -$50.7K 0.01% 939
2025
Q4 		$4.36M Buy
51,173
+1,864
+4% +$153K 0.01% 957
2025
Q3 		$3.83M Buy
49,309
+6,744
+16% +$527K 0.01% 1000
2025
Q2 		$3.33M Sell
42,565
-296
-0.7% -$22.1K 0.01% 988
2025
Q1 		$3.11M Sell
42,861
-234
-0.5% -$16.7K 0.01% 972
2024
Q4 		$3.19M Buy
43,095
+302
+0.7% +$21.1K 0.01% 957
2024
Q3 		$2.82M Sell
42,793
-16,873
-28% -$1.23M 0.01% 976
2024
Q2 		$5.51M Sell
59,666
-2,709
-4% -$240K 0.02% 700
2024
Q1 		$5.96M Sell
62,375
-14,239
-19% -$1.2M 0.02% 695
2023
Q4 		$5.84M Buy
76,614
+2,126
+3% +$148K 0.02% 671
2023
Q3 		$5.16M Buy
74,488
+3,750
+5% +$301K 0.02% 660
2023
Q2 		$6.67M Buy
+70,738
New +$6.15M 0.02% 600
2023
Q1 		– Sell
-166,798
Closed -$12.4M – 2600
2022
Q4 		$12.4M Buy
166,798
+15,259
+10% +$1.18M 0.05% 364
2022
Q3 		$12.5M Buy
+151,539
New +$14.6M 0.05% 321
2021
Q1 		– Sell
-67,023
Closed -$6.12M – 2281
2020
Q4 		$6.12M Sell
67,023
-2,182
-3% -$181K 0.03% 478
2020
Q3 		$5.52M Sell
69,205
-60,368
-47% -$4.71M 0.03% 454
2020
Q2 		$8.96M Buy
129,573
+27,525
+27% +$1.96M 0.06% 300
2020
Q1 		$6.42M Buy
102,048
+8,562
+9% +$617K 0.05% 330
2019
Q4 		$7.27M Buy
93,486
+1,167
+1% +$91.1K 0.05% 350
2019
Q3 		$6.77M Buy
92,319
+28,410
+44% +$2M 0.05% 355
2019
Q2 		$3.94M Sell
63,909
-2,259
-3% -$137K 0.03% 492
2019
Q1 		$4.22M Buy
66,168
+2,250
+4% +$128K 0.03% 452
2018
Q4 		$3.26M Sell
63,918
-5,505
-8% -$279K 0.03% 483
2018
Q3 		$4.03M Buy
69,423
+20,415
+42% +$998K 0.03% 471
2018
Q2 		$2.38M Buy
49,008
+1,065
+2% +$49.7K 0.02% 611
2018
Q1 		$2.23M Sell
47,943
-4,632
-9% -$201K 0.02% 610
2017
Q4 		$1.98M Buy
52,575
+22,134
+73% +$812K 0.02% 648
2017
Q3 		$1.11M Buy
30,441
+2,889
+10% +$110K 0.01% 870
2017
Q2 		$1.09M Buy
27,552
+2,580
+10% +$94.2K 0.01% 834
2017
Q1 		$783K Sell
24,972
-18,261
-42% -$572K 0.01% 956
2016
Q4 		$1.35M Buy
43,233
+2,871
+7% +$93K 0.02% 649
2016
Q3 		$1.62M Buy
+40,362
New +$1.52M 0.03% 500
2016
Q2 		– Sell
-39,543
Closed -$1.16M – 830
2016
Q1 		$1.16M Buy
39,543
+25,080
+173% +$692K 0.03% 477
2015
Q4 		$381K Sell
14,463
-321
-2% -$8.34K 0.01% 935
2015
Q3 		$350K Buy
14,784
+2,586
+21% +$62.4K 0.01% 990
2015
Q2 		$290K Buy
12,198
+1,710
+16% +$38.6K 0.01% 1523
2015
Q1 		$249K Buy
+10,488
New +$235K ﹤0.01% 1917
2014
Q2 		– Sell
-44,400
Closed -$549K – 2226
2014
Q1 		$549K Sell
44,400
-19,170
-30% -$221K 0.01% 1063
2013
Q4 		$697K Sell
63,570
-77,964
-55% -$879K 0.02% 889
2013
Q3 		$1.64M Buy
141,534
+78,504
+125% +$918K 0.05% 459
2013
Q2 		$706K Buy
+63,030
New +$746K 0.07% 315

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Janney Montgomery Scott's EW Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Edwards Lifesciences (EW) stake by 1.2% in Q1 2026, selling an estimated $50.7K and leaving 50,558 shares worth $4.05M. The position accounts for 0.01% of the portfolio, ranked #939.

Janney Montgomery Scott first reported a position in EW in Q2 2013 and has held it in 41 quarters since. The position peaked at $12.5M in Q3 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Janney Montgomery Scott held 50,558 shares of Edwards Lifesciences worth $4.05M as of Q1 2026.
  • Janney Montgomery Scott sold 615 Edwards Lifesciences shares in Q1 2026, an estimated $50.7K.
  • Edwards Lifesciences made up 0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #939 holding.
  • Janney Montgomery Scott first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 41 quarters since.
  • Janney Montgomery Scott's Edwards Lifesciences position peaked at $12.5M in Q3 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.